Literature DB >> 2475595

The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury.

M G Fehlings1, C H Tator, R D Linden.   

Abstract

There is evidence that posttraumatic ischemia is important in the pathogenesis of acute spinal cord injury (SCI). In the present study spinal cord blood flow (SCBF), measured by the hydrogen clearance technique, and motor and somatosensory evoked potentials (MEP and SSEP) were recorded to evaluate whether the administration of nimodipine and dextran 40, alone or in combination, could increase posttraumatic SCBF and improve axonal function in the cord after acute SCI. Thirty rats received a 53-gm clip compression injury on the cord at T-1 and were then randomly and blindly allocated to one of six treatment groups (five rats in each). Each group was given an intravenous infusion of one of the following over 1 hour, commencing 1 hour after SCI: placebo and saline; placebo and dextran 40; nimodipine 0.02 mg/kg and saline; nimodipine 0.02 mg/kg and dextran 40; nimodipine 0.05 mg/kg and saline; and nimodipine 0.05 mg/kg and dextran 40. The preinjury physiological parameters, including the SCBF at T-1 (mean +/- standard error of the mean: 56.84 +/- 4.51 ml/100 gm/min), were not significantly different (p greater than 0.05) among the treatment groups. Following SCI, there was a significant decrease in the SCBF at T-1 (24.55 +/- 2.99 ml/100 gm/min; p less than 0.0001) as well as significant changes in the MEP recorded from the spinal cord (MEP-C) (p less than 0.0001), the MEP recorded from the sciatic nerve (MEP-N) (p less than 0.0001), and the SSEP (p less than 0.002). Only the combination of nimodipine 0.02 mg/kg and dextran 40 increased the SCBF at T-1 (43.69 +/- 6.09 ml/100 gm/min; p less than 0.003) and improved the MEP-C (p less than 0.0001), MEP-N (p less than 0.04), and SSEP (p less than 0.002) following SCI. With this combination, the changes in SCBF were significantly related to improvement in axonal function in the motor tracts (p less than 0.0001) and somatosensory tracts (p less than 0.0001) of the cord. This study provides quantitative evidence that an increase in posttraumatic SCBF can significantly improve the function of injured spinal cord axons, and strongly implicates posttraumatic ischemia in the pathogenesis of acute SCI.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475595     DOI: 10.3171/jns.1989.71.3.0403

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  25 in total

1.  Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats.

Authors:  Bruno Benetti Junta Torres; Fátima Maria Caetano Caldeira; Mardelene Geísa Gomes; Rogéria Serakides; Aline de Marco Viott; Angélica Cavalheiro Bertagnolli; Fabíola Bono Fukushima; Karen Maciel de Oliveira; Marcus Vinícius Gomes; Eliane Gonçalves de Melo
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

2.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

3.  Effects of Human Erythropoietin on Functional Outcome of Patients with Traumatic Cervical Cord Injury; A Pilot Randomized Clinical Trial.

Authors:  Ehsan Ali Alibai; Fahim Baghban; Majid Reza Farrokhi; Navideh Mohebali; Mohammad Hossein Ashraf
Journal:  Bull Emerg Trauma       Date:  2015-07

Review 4.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

5.  Correlation between spinal cord blood flow and arterial diameter following acute spinal cord injury in rats.

Authors:  T Ohashi; T Morimoto; K Kawata; T Yamada; T Sakaki
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 6.  Emerging therapies for acute traumatic spinal cord injury.

Authors:  Jefferson R Wilson; Nicole Forgione; Michael G Fehlings
Journal:  CMAJ       Date:  2012-12-10       Impact factor: 8.262

Review 7.  Current and future medical therapeutic strategies for the functional repair of spinal cord injury.

Authors:  Tevfik Yılmaz; Erkan Kaptanoğlu
Journal:  World J Orthop       Date:  2015-01-18

8.  Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury.

Authors:  Shu Han; Sheila A Arnold; Srinivas D Sithu; Edward T Mahoney; Justin T Geralds; Phuong Tran; Richard L Benton; Melissa A Maddie; Stanley E D'Souza; Scott R Whittemore; Theo Hagg
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

9.  Effect of norepinephrine on spinal cord blood flow and parenchymal hemorrhage size in acute-phase experimental spinal cord injury.

Authors:  Marc Soubeyrand; Arnaud Dubory; Elisabeth Laemmel; Charles Court; Eric Vicaut; Jacques Duranteau
Journal:  Eur Spine J       Date:  2013-11-14       Impact factor: 3.134

10.  The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.

Authors:  Abdurrahman Cetin; Kemal Nas; Hüseyin Büyükbayram; Adnan Ceviz; Gönül Olmez
Journal:  Eur Spine J       Date:  2006-03-18       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.